Akèy › Metiyè › Medical Scientists, Except Epidemiologists › Lexington, MA
Medical Scientists, Except Epidemiologists nan Lexington, MA: Salè H-1B
37 aplikasyon kondisyon travay pou okipasyon sa a ak yon sit travay nan Lexington, MA. Salè baz medyàn ofri $141,084; mwatye mitan $117,714–$158,945.
Pa nivo salè
| Nivo revni | Salè medyan |
|---|---|
| Nivo I (antre) | $132,500 |
| Nivo II (kalifye) | $110,000 |
| Nivo III (eksperyans) | $135,462 |
| Nivo IV (plen kompetans) | $159,317 |
Depatman Travay la etabli kat nivo salè prevanlan pou chak okipasyon ak zòn, soti nan Nivo I (antre) rive nan Nivo IV (plen kompetans). Anplwayè a chwazi nivo ki koresponn ak kondisyon travay la.
Anplwayè yo
| Anplwayè | LCA | Salè medyan |
|---|---|---|
| Takeda Development Center Americas, Inc. | 11 | $140,000 |
| SalioGen Therapeutics Inc. | 4 | $99,460 |
| Takeda Pharmaceuticals USA, Inc. | 3 | $150,000 |
| Voyager Therapeutics, Inc. | 3 | $159,771 |
| Cystic Fibrosis Foundation | 3 | $143,000 |
| Keros Therapeutics | 2 | $106,500 |
| Novo Nordisk Research & Development US, Inc. | 2 | $154,942 |
| Takeda Pharmaceuticals America Inc. | 2 | $164,480 |
| General Hospital Corporation | 1 | $110,000 |
| Agenus Inc. | 1 | $110,000 |
| Fosun Pharma USA, Inc. | 1 | $95,400 |
| Curis, Inc. | 1 | $205,000 |
| Dicerna Pharmaceuticals, Inc. | 1 | $150,000 |
| KSQ Therapeutics, Inc. | 1 | $158,882 |
| Bicycle Therapeutics, Inc. | 1 | $135,000 |
Tit travay
- Scientist I3
- Scientist3
- Senior Scientist I3
- Senior Research Associate2
- Sr. Staff Engineer CMC2
- Scientist II2
- Medical Science Liaison2
- Researcher1
- Senior Clinical Trials Associate Manager1
- Scientist, In Vivo1
- Translational Medicine Scientist, Clinical Development1
- Associate Scientific Director1
- Scientist CMC1
- Associate Scientist1
- Associate Director Clinical Sciences1
Pwonse H-1B nan Lexington, MA →
Salè yo se fen ki pi ba nan salè yo ofri sou chak aplikasyon, konvèti nan yon montan anyèl; estatistik yo itilize sèlman aplikasyon tan plen sètifye. Yon LCA pa yon apwobasyon visa epi yon sèl LCA ka kouvri plizyè pozisyon. Sous: Depatman Travay Etazini, Done Divulgasyon LCA OFLC, ane fiskal 2023–2026 (dènye desizyon Jun 30, 2026).